New Legs Put Tired Biotech Story Back in the Game

The Case

Most babies develop a natural resistance to respiratory syncitial virus (RSV), but the condition can be fatal to premature infants born with underdeveloped lungs and weakened
immune systems. Each year, RSV results in more than 126,000 hospitalizations and 2% of those children who are admitted die from RSV complications.